These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 20385121)
21. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity. Baek SJ; Wilson LC; Hsi LC; Eling TE J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986 [TBL] [Abstract][Full Text] [Related]
22. Rosiglitazone induction of Insig-1 in white adipose tissue reveals a novel interplay of peroxisome proliferator-activated receptor gamma and sterol regulatory element-binding protein in the regulation of adipogenesis. Kast-Woelbern HR; Dana SL; Cesario RM; Sun L; de Grandpre LY; Brooks ME; Osburn DL; Reifel-Miller A; Klausing K; Leibowitz MD J Biol Chem; 2004 Jun; 279(23):23908-15. PubMed ID: 15073165 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells. Chang HK; Kim DS; Chae JJ; Kim M; Myong JP; Lee KH; Lee MW; Park TC Biochem Biophys Res Commun; 2017 Jan; 482(4):843-848. PubMed ID: 27888104 [TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Baek SJ; Kim KS; Nixon JB; Wilson LC; Eling TE Mol Pharmacol; 2001 Apr; 59(4):901-8. PubMed ID: 11259636 [TBL] [Abstract][Full Text] [Related]
25. PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium. Scoditti E; Massaro M; Carluccio MA; Distante A; Storelli C; De Caterina R Cardiovasc Res; 2010 May; 86(2):302-10. PubMed ID: 20032081 [TBL] [Abstract][Full Text] [Related]
26. Kruppel-like factor 4 is a novel mediator of selenium in growth inhibition. Liu S; Zhang H; Zhu L; Zhao L; Dong Y Mol Cancer Res; 2008 Feb; 6(2):306-13. PubMed ID: 18314491 [TBL] [Abstract][Full Text] [Related]
27. Down-regulation of peroxisome proliferator-activated receptor gamma in human cervical carcinoma. Jung TI; Baek WK; Suh SI; Jang BC; Song DK; Bae JH; Kwon KY; Bae JH; Cha SD; Bae I; Cho CH Gynecol Oncol; 2005 May; 97(2):365-73. PubMed ID: 15863131 [TBL] [Abstract][Full Text] [Related]
28. Peroxisome proliferator-activated receptor gamma interacts with CIITA x RFX5 complex to repress type I collagen gene expression. Xu Y; Farmer SR; Smith BD J Biol Chem; 2007 Sep; 282(36):26046-56. PubMed ID: 17611194 [TBL] [Abstract][Full Text] [Related]
29. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway. Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989 [TBL] [Abstract][Full Text] [Related]
30. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes. Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576 [TBL] [Abstract][Full Text] [Related]
31. Role of nonsteroidal anti-inflammatory drug-activated gene-1 in docetaxel-induced cell death of human colorectal cancer cells with different p53 status. Kim IY; Park SY; Kang Y; Thapa D; Choi HG; Kim JA Arch Pharm Res; 2011 Feb; 34(2):323-30. PubMed ID: 21380817 [TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase inhibitors induce apoptosis in sinonasal cancer cells by increased expression of nonsteroidal anti-inflammatory drug-activated gene. Kim JH; Chang JH; Rhee KH; Yoon JH; Kwon SH; Song K; Lee KW; Cho CI; Jeon JH; Kim KS Int J Cancer; 2008 Apr; 122(8):1765-73. PubMed ID: 18076062 [TBL] [Abstract][Full Text] [Related]
34. PPARγ agonist efatutazone and gefitinib synergistically inhibit the proliferation of EGFR-TKI-resistant lung adenocarcinoma cells via the PPARγ/PTEN/Akt pathway. Ni J; Zhou LL; Ding L; Zhao X; Cao H; Fan F; Li H; Lou R; Du Y; Dong S; Liu S; Wang Z; Ma R; Wu J; Feng J Exp Cell Res; 2017 Dec; 361(2):246-256. PubMed ID: 29080795 [TBL] [Abstract][Full Text] [Related]
35. Regulation of cigarette smoke-induced toll-like receptor 4 expression by peroxisome proliferator-activated receptor-gamma agonists in bronchial epithelial cells. Yin Y; Hou G; Li ER; Wang QY; Kang J Respirology; 2013 Nov; 18 Suppl 3():30-9. PubMed ID: 24188201 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of glutathione synthesis reverses Krüppel-like factor 4-mediated cisplatin resistance. Jia Y; Zhang W; Liu H; Peng L; Yang Z; Lou J Cancer Chemother Pharmacol; 2012 Feb; 69(2):377-85. PubMed ID: 21833590 [TBL] [Abstract][Full Text] [Related]
37. EZH2-mediated inhibition of KLF14 expression promotes HSCs activation and liver fibrosis by downregulating PPARγ. Du Z; Liu M; Wang Z; Lin Z; Feng Y; Tian D; Xia L Cell Prolif; 2021 Jul; 54(7):e13072. PubMed ID: 34031939 [TBL] [Abstract][Full Text] [Related]
38. Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates trefoil factor family 2 (TFF2) expression in gastric epithelial cells. Shimada T; Fujii Y; Koike T; Tabei K; Namatame T; Yamagata M; Tajima A; Yoneda M; Terano A; Hiraishi H Int J Biochem Cell Biol; 2007; 39(3):626-37. PubMed ID: 17118693 [TBL] [Abstract][Full Text] [Related]
39. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner. Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005 [TBL] [Abstract][Full Text] [Related]
40. The Kruppel-like KLF4 transcription factor, a novel regulator of urokinase receptor expression, drives synthesis of this binding site in colonic crypt luminal surface epithelial cells. Wang H; Yang L; Jamaluddin MS; Boyd DD J Biol Chem; 2004 May; 279(21):22674-83. PubMed ID: 15031282 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]